Healthcare provider profile · identity verified

Ira Liebross, MD

Family Practice · FLEMINGTON, NJ · NPI 1457359713

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	419	111
Levothyroxine Sodium	Levothyroxine Sodium	292	71
Amlodipine Besylate	Amlodipine Besylate	252	71
Metoprolol Succinate	Metoprolol Succinate	230	60
Losartan Potassium	Losartan Potassium	207	53
Rosuvastatin Calcium	Rosuvastatin Calcium	191	59
Hydrochlorothiazide	Hydrochlorothiazide	189	50
Metformin Hcl	Metformin Hcl	134	35
Tamsulosin Hcl	Tamsulosin Hcl	132	43
Lisinopril	Lisinopril	127	34
Simvastatin	Simvastatin	120	33
Omeprazole	Omeprazole	113	33
Gabapentin	Gabapentin	89	19
Furosemide	Furosemide	87	17
Zolpidem Tartrate	Zolpidem Tartrate	85	20
Albuterol Sulfate Hfa	Albuterol Sulfate	84	32
Allopurinol	Allopurinol	83	22
Sertraline Hcl	Sertraline Hcl	80	23
Escitalopram Oxalate	Escitalopram Oxalate	79	24
Mounjaro	Tirzepatide	79	suppressed
Metformin Hcl Er	Metformin Hcl	77	19
Jardiance	Empagliflozin	76	15
Finasteride	Finasteride	69	19
Alprazolam	Alprazolam	67	26
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	66	suppressed
Eliquis	Apixaban	63	13
Enalapril Maleate	Enalapril Maleate	62	16
Prednisone	Prednisone	59	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	56	16
Famotidine	Famotidine	54	16
Amoxicillin	Amoxicillin	53	42
Ezetimibe	Ezetimibe	53	16
Myrbetriq	Mirabegron	53	11
Clonazepam	Clonazepam	52	suppressed
Montelukast Sodium	Montelukast Sodium	52	14
Spironolactone	Spironolactone	52	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	12
Rybelsus	Semaglutide	48	suppressed
Carvedilol	Carvedilol	47	11
Pantoprazole Sodium	Pantoprazole Sodium	47	14
Azithromycin	Azithromycin	46	35
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	32
Triamcinolone Acetonide	Triamcinolone Acetonide	43	27
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Lorazepam	Lorazepam	41	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Glipizide Er	Glipizide	38	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Np Thyroid	Thyroid,pork	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	17
Doxycycline Hyclate	Doxycycline Hyclate	36	34
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	36	34
Meloxicam	Meloxicam	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Methylprednisolone	Methylprednisolone	28	22
Cefuroxime	Cefuroxime Axetil	27	20
Cephalexin	Cephalexin	27	22
Nystatin	Nystatin	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Atenolol	Atenolol	25	suppressed
Levofloxacin	Levofloxacin	25	17
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Ozempic	Semaglutide	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	13
Armour Thyroid	Thyroid,pork	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Colchicine	Colchicine	22	13
Diazepam	Diazepam	22	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Estradiol	Estradiol	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Ramipril	Ramipril	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Trazodone Hcl	Trazodone Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Minoxidil	Minoxidil	15	suppressed
Triazolam	Triazolam	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Cholestyramine Light	Cholestyramine	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Torsemide	Torsemide	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Valium	Diazepam	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error